Table 5.
Indirect effect | Direct effect | Indirect/direct effect | Mediator tests | |||
---|---|---|---|---|---|---|
Aroian | Goodman | Sobel | ||||
Systolic Blood Pressure(mmHg) | −0.02 | −0.36 | 0.07 | −4.20 | −4.26 | −4.23 |
HOMA_B | −0.27 | −0.34 | 0.78 | −5.07 | −5.10 | −5.08 |
Diastolic Blood Pressure(mmHg) | −0.05 | −0.31 | 0.17 | −6.94 | −6.97 | −6.95 |
GGT (IU/L) | −0.47 | −0.27 | 1.74 | −7.43 | −7.45 | −7.44 |
Two Hour Insulin (µU/mL) | −0.50 | −0.28 | 1.78 | −7.52 | −7.54 | −7.53 |
HOMA_IR | −0.02 | −0.29 | 0.06 | −7.73 | −7.75 | −7.74 |
Two Hour Glucose (mg/dL) | −0.39 | −0.28 | 1.38 | −8.37 | −8.40 | −8.39 |
Total Cholesterol (mg/dL) | −0.53 | −0.26 | 2.02 | −8.69 | −8.71 | −8.70 |
HDL (mg/dL) | −0.50 | −0.25 | 1.96 | −8.78 | −8.80 | −8.79 |
LDL (mg/dL) | −0.59 | −0.23 | 2.57 | −9.87 | −9.90 | −9.88 |
TG (mg/dL) | −0.57 | −0.18 | 3.16 | −10.99 | −11.01 | −11.00 |
FBS (mg/dL) | −0.71 | −0.13 | 5.35 | −11.12 | −11.13 | −11.12 |
ALT (IU/L) | −0.67 | −0.15 | 4.32 | −11.40 | −11.42 | −11.41 |
Weight (Kg) | −0.65 | −0.16 | 4.02 | −11.64 | −11.66 | −11.65 |
AST (IU/L) | −0.64 | −0.14 | 4.45 | −12.00 | −12.02 | −12.01 |
Age (years) | −0.80 | −0.08 | 9.71 | −12.01 | −12.03 | −12.02 |
Fast Insulin (µU/mL) | −0.58 | −0.09 | 6.41 | −12.51 | −12.53 | −12.52 |
BMI | −0.54 | −0.11 | 4.74 | −12.55 | −12.57 | −12.56 |
Waist (cm) | −0.75 | −0.05 | 14.34 | −12.64 | −12.66 | −12.65 |
ALT, alanine aminotransferase; AST, Aspartate Aminotransferase; BMI, body mass index; FBS, Fasting Blood Sugar; GGT, gamma-glutamyl transferase; HDL, high-density lipoprotein; HOMA-IR, homeostasis model of insulin resistance; HOMA-β, Homeostatic model assessment of β cell function; LDL, low-density lipoprotein; TG, Triglyceride.